Ozkorkmaz Ebru Gokalp, Gul Nursel, Ozluk Aydin, Ozay Yusuf
Department of Nursing, Faculty of Health Sciences, Ankara Yildirim Beyazit University, Ankara, Turkey.
Department of Biology, Faculty of Science, Ankara University, Ankara, Turkey.
J Microsc Ultrastruct. 2018 Oct-Dec;6(4):192-196. doi: 10.4103/JMAU.JMAU_31_18.
The current study investigated the efficacy of methotrexate (MTX) on liver tissue cells of Balb/c mice at the ultrastructural level using transmission electron microscopy.
This agent is well known and used as a chemotherapeutic agent for a long time and not selective for cancer cells so, healthy cells beside cancer cells are also affected by MTX.
Experimental animals were divided into two groups; the first group was kept without treatment and served as the control, the second group was treated with 115 mg/kg MTX i.p. once weekly for 4 weeks and sacrificed under anesthesia after the 4th week. The liver tissues were osmium fixed and embedded in araldite, sectioned and observed under transmission electron microscope.
Normal cell ultrastructure was determined in the control group whereas the liver cells of the MTX-treated group revealed ultrastructural alterations, such as the increase in lipid droplets, discontinuity of rough endoplasmic reticulum cisternae and vacuole formation. In addition, the loss of cytoplasmic material in hepatocytes was also evident. Condensation of nuclear chromatin and fusion of nucleic membranes were observed in the liver cells of the treated group.
Results of the study indicated that MTX, used for different types of medical treatment, disturbed liver cell ultrastructure.
本研究采用透射电子显微镜在超微结构水平上研究甲氨蝶呤(MTX)对Balb/c小鼠肝组织细胞的疗效。
该药物久负盛名且长期用作化疗药物,对癌细胞无选择性,因此除癌细胞外,健康细胞也会受到MTX的影响。
将实验动物分为两组;第一组不进行治疗作为对照组,第二组腹腔注射115mg/kg MTX,每周一次,共4周,第4周后在麻醉下处死。肝组织经锇固定,包埋于环氧树脂中,切片后在透射电子显微镜下观察。
对照组确定为正常细胞超微结构,而MTX治疗组的肝细胞显示出超微结构改变,如脂滴增加、粗面内质网池连续性中断和空泡形成。此外,肝细胞中细胞质物质的丢失也很明显。在治疗组的肝细胞中观察到核染色质凝聚和核膜融合。
研究结果表明,用于不同类型医疗的MTX会干扰肝细胞超微结构。